Company
L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
NeuroPath’s platform captures data and detects events from the daily living activities of patients with neurodegenerative diseases by using state-of-the-art technologies in motion capturing, QoL surveys, wearables and voice detection.
Enghien, Région wallonne, Belgium
Send a message
Anglais
Anglais
NeuroPath’s platform captures data and detects events from the daily living activities of patients with neurodegenerative diseases by using state-of-the-art technologies in motion capturing, Quality of Life surveys, wearables and voice detection.
Using AI, data is analyzed and transformed into objective parameters of disease progression to create insights into care path adherence, treatment results, drug efficacy and personalized care that can be shared with all stakeholders.
...NeuroPath’s platform captures data and detects events from the daily living activities of patients with neurodegenerative diseases by using state-of-the-art technologies in motion capturing, Quality of Life surveys, wearables and voice detection.
Using AI, data is analyzed and transformed into objective parameters of disease progression to create insights into care path adherence, treatment results, drug efficacy and personalized care that can be shared with all stakeholders.
Due to its hardware agnostic approach, NeuroPath can develop algorithms by plugging in different sensors and data sets. This can also entail the incorporation of Internet of Thing (IoT) and invisible Patient Reported Outcomes (iPROs). A graphic user interface facilitates the consultation of the reports as well as the custom analytics of the results.
“I see my neurologist every six months for a thirty-minute session. That leaves 8,765 hours per year when my disease is not being monitored.” Parkinson’s disease is very complex, and the progression of the disease is highly individual. Therefore, the need for a constant visibility on the disease progression and the impact of the treatment regimen is crucial to the quality of life of the patient.
NeuroPath supports caregivers and clinicians in personalizing care pathways by engaging patients, significant others and the full ecosystem of clinicians around the patient. Eventually, big data will benefit pharma, CRO and payers.
3
Followers
1
Like
Start in September 2016 - January 2018
September 2016 - January 2018
Pilot project commitment at 3 hospitals in Belgium Project partners on board
Q1 2018 - Q4 2019
600K equity and 300K grants raised Agreements Texas A&M & Nortwestern Medicine Chicago office
2020
2.2 M subsidies Wallonia 0.4 M subsidies H2020 First product tested , ready Winner 2nd prize Polsky
to be continued ...